CEO Jacob Thaysen sees Illumina on track to meet his original goal of high single-digit revenue growth by 2027 despite ...

Illumina said on Tuesday it has partnered with the Broad Institute to develop new kits that will allow large-scale gene sequencing using a novel method based on the Nobel Prize-winning CRISPR ...

Illumina CEO Jacob Thaysen made clear the sequencing giant is returning to its traditional role of creating instruments for researchers.

Illumina is a global leader in developing the tools that help scientists analyze strands of DNA as well as large amounts of complex genetic data through multiomic sequencing.

According to Strömqvist, this format enables 3D DNA sequencing in situ. The size of Single Technologies’ 3D DNA sequencing matrix (left) compared to Illumina’s S4 flow cell (right).

"Cost is a direct relationship to technology advances," Dr. Steven Barnard—chief technology officer of Illumina, the market leader in DNA sequencing machines—told Newsweek.

Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the appointment ...

The cost of DNA sequencing has been dropping for years. Since the $1000 genome claim, first made by Illumina in 2014, multiple companies have claimed a $100 genome, including Ultima Genomics—a ...